St. Jude Medical's game-changing Nanostim pacemaker still looks strong in 1-year results from an early study of heart failure patients.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/SIyoAo
Cap comentari:
Publica un comentari a l'entrada